Kanglin Biotec
Accessing X003
X003 is currently approved for clinical use in Nansha, Guangdong, and treatment is provided exclusively at Guangzhou First People's Hospital, Nansha Branch, in collaboration with Kanglin Biotech’s certified medical team. This specialized center is equipped with GMP-compliant manufacturing facilities and state-of-the-art hematology and gene therapy units, ensuring every step of the treatment meets international quality and safety standards.
Guangzhou First People's Hospital (Nansha)
The treatment process requires a series of coordinated steps that must be done under strict medical supervision at our GMP-compliant facility in Guangzhou First People's Hospital, Nansha Branch.
Guangzhou First People's Hospital is a world-class facility with an experienced medical team dedicated to providing the best care for patients undergoing gene therapy.
Because X003 is an advanced, highly regulated gene therapy, it can only be administered in approved facilities that meet strict manufacturing and clinical quality requirements.
Our Nansha site is currently one of the few in the world certified to perform the entire process — from cell collection and modification to infusion and long-term monitoring — under one roof.
This centralized care model allows our team to ensure precision, safety, and full regulatory oversight, giving every patient the best chance at a successful outcome.
While travel may seem challenging, it allows you to receive personalized care directly from the X003 development team, who bring years of experience in gene therapy and hematological disorders.
By traveling to Guangzhou, patients gain access to cutting-edge facilities and specialized expertise not yet widely available in other regions.
Ready to Begin?
Patients interested in exploring X003 treatment can begin by completing our Pre-Screening Survey.
Our team will contact you to confirm eligibility, discuss next steps, and provide personalized guidance for your journey.